Pathogenic role of IgA receptors in IgA nephropathy

Contributions to Nephrology

Volumn 157, Issue , 2007, Pages 64-69

  Monteiro, Renato C ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IGA RECEPTOR; IMMUNOGLOBULIN A; UNCLASSIFIED DRUG;

CONFERENCE PAPER; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; PATHOLOGY;

GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; RECEPTORS, FC;

EID: 34249089246     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102306     Document Type: Conference Paper

References (19)

1. Barratt J, Feehally J: IgA nephropathy. J Am Soc Nephrol 2005;16:2088-2097.
2. Monteiro RC, Moura IC, Launay P, et al: Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 2002;8:464-468.
3. Berger J, Yaneva H, Nabarra B, et al: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 1975;7:232-241.
4. Novak J, Julian BA, Tomana M, et al: Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 2001;21:310-327.
5. Grossetete B, Launay P, Lehuen A, et al: Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int 1998;53: 1321-1335.
6. Launay P, Grossetete B, Arcos-Fajardo M, et al: Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 2000;191:1999-2009.
7. Van Der Boog PJ, De Fijter JW, Van Kooten C, et al: Complexes of IgA with FcαRI/CD89 are not specific for primary IgA nephropathy. Kidney Int 2003;63:514-521.
8. van der Boog PJ, van Kooten C, de Fijter JW, et al: Role of macromolecular IgA in IgA nephropathy. Kidney Int 2005;67:813-821.
9. Rifai A, Fadden K, Morrison SL, et al: The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 2000;191:2171-2182.
10. Gomez-Guer rero C, Suzuki Y, Egido J: The identification of IgA receptors in human mesangial cells: in the search for 'Eldorado'. Kidney Int 2002;62:715-717.
11. Moura IC, Centelles MN, Arcos-Fajardo M, et al: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001;194:417-425.
12. Haddad E, Moura IC, Arcos-Fajardo M, et al: Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis: association between CD71 expression and IgA deposits. J Am Soc Nephrol 2003;14:327-337.
13. Moura IC, Arcos-Fajardo M, Sadaka C, et al: Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004;15: 622-634.
14. Moura IC, Arcos-Fajardo M, Gdoura A, et al: Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005;16:2667-2676.
15. McDonald KJ, Cameron AJ, Allen JM, et al: Expression of Fcα/μ receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 2002;290:438-442.
16. Arima S, Nakayama M, Naito M, et al: Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 1991;39:684-692.
17. Falk MC, Ng G, Zhang GY, et al: Infiltration of the kidney by αβ and γδ T cells: effect on progression in IgA nephropathy. Kidney Int 1995;47:177-185.
18. Monteiro RC, Grossetete B, Nguyen AT, et al: Dysfunctions of Fcα receptors by blood phagocytic cells in IgA nephropathy. Contrib Nephrol 1995;111:116-122.
19. Kanamaru Y, Arcos-Fajardo M, Moura IC, et al: Fcα receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcRγ adaptor. Eur J Immunol (in press).